Mingjuan Lisa Zhang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Cyst | 4 | 2025 | 372 | 2.540 |
Why?
|
Pancreatic Neoplasms | 11 | 2025 | 5446 | 2.070 |
Why?
|
Urothelium | 5 | 2020 | 275 | 1.790 |
Why?
|
Cytodiagnosis | 6 | 2024 | 452 | 1.640 |
Why?
|
Urologic Neoplasms | 5 | 2020 | 314 | 1.560 |
Why?
|
Urine | 5 | 2020 | 362 | 1.470 |
Why?
|
Carcinoma | 6 | 2022 | 2332 | 1.140 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2024 | 526 | 0.830 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2020 | 2195 | 0.810 |
Why?
|
Jaundice | 1 | 2022 | 95 | 0.770 |
Why?
|
Colitis, Ischemic | 1 | 2021 | 32 | 0.750 |
Why?
|
Neuroendocrine Tumors | 2 | 2024 | 659 | 0.730 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1757 | 0.730 |
Why?
|
Digestive System | 1 | 2022 | 244 | 0.730 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2024 | 343 | 0.700 |
Why?
|
Enterocolitis | 1 | 2021 | 106 | 0.690 |
Why?
|
Digestive System Diseases | 1 | 2022 | 152 | 0.690 |
Why?
|
Pancreas | 2 | 2024 | 1700 | 0.690 |
Why?
|
Cyst Fluid | 3 | 2025 | 86 | 0.670 |
Why?
|
Body Fluids | 1 | 2021 | 321 | 0.640 |
Why?
|
Cell Nucleus | 3 | 2017 | 2885 | 0.640 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.590 |
Why?
|
Cystadenoma, Serous | 1 | 2018 | 100 | 0.580 |
Why?
|
Mediastinal Neoplasms | 1 | 2020 | 403 | 0.560 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.560 |
Why?
|
Urinary Tract | 1 | 2020 | 305 | 0.550 |
Why?
|
Osteosarcoma | 1 | 2023 | 911 | 0.550 |
Why?
|
Adenocarcinoma | 4 | 2023 | 6395 | 0.540 |
Why?
|
Surgical Instruments | 1 | 2018 | 381 | 0.500 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2017 | 169 | 0.500 |
Why?
|
Glaucoma | 2 | 2015 | 1194 | 0.480 |
Why?
|
Hypoglycemia | 1 | 2022 | 895 | 0.480 |
Why?
|
Eye Neoplasms | 1 | 2017 | 306 | 0.480 |
Why?
|
Cytoplasm | 2 | 2017 | 1505 | 0.480 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2022 | 1105 | 0.470 |
Why?
|
Hematuria | 1 | 2016 | 232 | 0.470 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 957 | 0.450 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1164 | 0.450 |
Why?
|
Phacoemulsification | 1 | 2015 | 151 | 0.440 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2017 | 794 | 0.430 |
Why?
|
Trabeculectomy | 1 | 2015 | 174 | 0.430 |
Why?
|
Intraocular Pressure | 2 | 2015 | 1304 | 0.380 |
Why?
|
Sarcoma | 1 | 2023 | 1806 | 0.380 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1206 | 0.370 |
Why?
|
Lymphoma | 1 | 2020 | 1898 | 0.360 |
Why?
|
Biopsy | 6 | 2024 | 6793 | 0.360 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2565 | 0.350 |
Why?
|
Neoplasm Staging | 2 | 2024 | 11244 | 0.330 |
Why?
|
Flow Cytometry | 1 | 2020 | 5902 | 0.320 |
Why?
|
Cataract | 1 | 2015 | 837 | 0.320 |
Why?
|
Specimen Handling | 2 | 2024 | 708 | 0.300 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1907 | 0.290 |
Why?
|
Biopsy, Fine-Needle | 4 | 2024 | 1135 | 0.270 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 13014 | 0.260 |
Why?
|
Colonic Neoplasms | 3 | 2022 | 2541 | 0.260 |
Why?
|
Observer Variation | 3 | 2024 | 2622 | 0.260 |
Why?
|
Therapeutic Irrigation | 2 | 2017 | 297 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3239 | 0.250 |
Why?
|
Humans | 44 | 2025 | 768166 | 0.250 |
Why?
|
Middle Aged | 18 | 2025 | 223492 | 0.250 |
Why?
|
Aged | 17 | 2025 | 171504 | 0.250 |
Why?
|
Aged, 80 and over | 9 | 2025 | 59629 | 0.250 |
Why?
|
Triage | 2 | 2023 | 997 | 0.230 |
Why?
|
Congo Red | 1 | 2024 | 49 | 0.230 |
Why?
|
Male | 21 | 2025 | 364719 | 0.220 |
Why?
|
Female | 21 | 2025 | 397192 | 0.210 |
Why?
|
Carcinoembryonic Antigen | 1 | 2024 | 338 | 0.200 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9263 | 0.200 |
Why?
|
Pancreatic Diseases | 1 | 2024 | 354 | 0.200 |
Why?
|
Adult | 13 | 2025 | 223646 | 0.180 |
Why?
|
Erythroblasts | 1 | 2021 | 142 | 0.180 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.170 |
Why?
|
Mutation | 1 | 2025 | 30238 | 0.170 |
Why?
|
Staining and Labeling | 1 | 2024 | 1081 | 0.170 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10873 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.170 |
Why?
|
Immunohistochemistry | 3 | 2024 | 11095 | 0.170 |
Why?
|
Erythroid Cells | 1 | 2021 | 237 | 0.160 |
Why?
|
Nuclear Envelope | 1 | 2020 | 163 | 0.160 |
Why?
|
Facial Neoplasms | 1 | 2020 | 126 | 0.160 |
Why?
|
Amyloid | 1 | 2024 | 854 | 0.160 |
Why?
|
Barrett Esophagus | 1 | 2023 | 495 | 0.160 |
Why?
|
Urinalysis | 1 | 2020 | 370 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4598 | 0.150 |
Why?
|
Orbital Neoplasms | 1 | 2020 | 223 | 0.150 |
Why?
|
Gastritis | 1 | 2019 | 199 | 0.150 |
Why?
|
World Health Organization | 1 | 2024 | 1329 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2020 | 794 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2022 | 557 | 0.140 |
Why?
|
Hematology | 1 | 2021 | 243 | 0.140 |
Why?
|
Pathology | 1 | 2020 | 270 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 260 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1767 | 0.130 |
Why?
|
Neoplasm Invasiveness | 1 | 2024 | 3620 | 0.130 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 15454 | 0.130 |
Why?
|
Diarrhea | 1 | 2022 | 1320 | 0.120 |
Why?
|
Stomach | 1 | 2019 | 701 | 0.120 |
Why?
|
BK Virus | 1 | 2016 | 120 | 0.120 |
Why?
|
Microscopy | 1 | 2020 | 909 | 0.120 |
Why?
|
Neurofibromatosis 1 | 1 | 2020 | 561 | 0.120 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3948 | 0.120 |
Why?
|
Trabecular Meshwork | 1 | 2015 | 101 | 0.120 |
Why?
|
Lymphocytes | 1 | 2022 | 2614 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2521 | 0.110 |
Why?
|
Prognosis | 4 | 2024 | 30010 | 0.110 |
Why?
|
Polyomavirus Infections | 1 | 2016 | 192 | 0.110 |
Why?
|
Europe | 1 | 2020 | 3436 | 0.110 |
Why?
|
Tumor Virus Infections | 1 | 2016 | 437 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1668 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2025 | 3671 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6974 | 0.100 |
Why?
|
Adipose Tissue | 1 | 2024 | 3329 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3556 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2159 | 0.100 |
Why?
|
Colon | 1 | 2019 | 1801 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2024 | 81762 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4035 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1242 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1399 | 0.090 |
Why?
|
Coloring Agents | 2 | 2024 | 565 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2935 | 0.090 |
Why?
|
Forkhead Transcription Factors | 3 | 2022 | 1625 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2429 | 0.090 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39348 | 0.080 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2907 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2981 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2022 | 2059 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6847 | 0.070 |
Why?
|
Cohort Studies | 4 | 2020 | 41754 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20227 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4058 | 0.060 |
Why?
|
Young Adult | 3 | 2024 | 60066 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3390 | 0.060 |
Why?
|
Quality Improvement | 1 | 2021 | 3857 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14729 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13290 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3703 | 0.060 |
Why?
|
Paraffin Embedding | 1 | 2024 | 307 | 0.050 |
Why?
|
Tissue Fixation | 1 | 2024 | 246 | 0.050 |
Why?
|
Stents | 1 | 2015 | 3195 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8542 | 0.050 |
Why?
|
Formaldehyde | 1 | 2024 | 362 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5432 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5717 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
Advisory Committees | 1 | 2024 | 797 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14164 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 431 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 570 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10399 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 22291 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13586 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2020 | 366 | 0.030 |
Why?
|
Faculty | 1 | 2020 | 383 | 0.030 |
Why?
|
Amyloidosis | 1 | 2024 | 878 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3284 | 0.030 |
Why?
|
Photography | 1 | 2017 | 537 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 65371 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4833 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2954 | 0.020 |
Why?
|
Prospective Studies | 1 | 2014 | 54926 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36743 | 0.020 |
Why?
|
Child | 1 | 2017 | 80917 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 89169 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4648 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4428 | 0.020 |
Why?
|
Transcription Factors | 1 | 2020 | 12168 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 9015 | 0.010 |
Why?
|
United States | 1 | 2023 | 73039 | 0.010 |
Why?
|